| scholarly article | Q13442814 |
| P2093 | author name string | F F Zhu | |
| L Z Yang | |||
| P2860 | cites work | Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis | Q24301803 |
| Increased generation of fibrocytes in thyroid-associated ophthalmopathy | Q33586738 | ||
| Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males | Q33738336 | ||
| Cytokines, Graves' disease, and thyroid-associated ophthalmopathy | Q33889209 | ||
| Thyroid associated ophthalmopathy - a review | Q34220709 | ||
| Interleukin-8 and the chemokine family. | Q34303829 | ||
| A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. | Q34782210 | ||
| Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy | Q35671939 | ||
| New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy | Q35785131 | ||
| Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy | Q36437367 | ||
| Inhibition of G-Protein βγ Signaling Decreases Levels of Messenger RNAs Encoding Proinflammatory Cytokines in T Cell Receptor-Stimulated CD4(+) T Helper Cells | Q36797406 | ||
| A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy | Q36817224 | ||
| Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. | Q36951623 | ||
| Epidemiology of Graves' orbitopathy. | Q37751752 | ||
| Evaluating Graves' orbitopathy | Q38013209 | ||
| Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease. | Q38013212 | ||
| Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy | Q38013216 | ||
| Current Insights into the Pathogenesis of Graves' Ophthalmopathy | Q38585018 | ||
| Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. | Q38633022 | ||
| Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy | Q38671312 | ||
| Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease? | Q38963406 | ||
| Thyroid eye disease: a review | Q38971992 | ||
| Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro. | Q39093117 | ||
| Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease | Q39430686 | ||
| Association of Polymorphisms in Toll-Like Receptors 4 and 9 with Autoimmune Thyroid Disease in Korean Pediatric Patients | Q41622992 | ||
| Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy | Q41640757 | ||
| Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists | Q42486826 | ||
| Identification and Functional Characterization of ST3GAL5 and ST8SIA1 Variants in Patients with Thyroid-Associated Ophthalmopathy. | Q42646967 | ||
| Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question | Q42667849 | ||
| The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event | Q43205575 | ||
| Association studies of interleukin-8 gene in Graves' disease and Graves' ophthalmopathy | Q43714135 | ||
| Immune-Neuroendocrine Interactions: Evolution, Ecology, and Susceptibility to Illness. | Q47113917 | ||
| Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra. | Q48503479 | ||
| Orbital decompression for thyroid eye disease: methods, outcomes, and complications. | Q49829361 | ||
| Modulation of hyaluronan polymer size regulates proliferation of perimysial fibroblasts in thyroid eye disease. | Q50110595 | ||
| Differential Gene Expression Profiling of Orbital Adipose Tissue in Thyroid Orbitopathy. | Q50797233 | ||
| Gene expression in Graves' ophthalmopathy and arm lymphedema: similarities and differences. | Q54376657 | ||
| Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin | Q82835636 | ||
| Current and Emerging Treatment Strategies for Graves' Orbitopathy | Q91118565 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| limma | Q112236343 | ||
| P433 | issue | 1 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2019-01-01 | |
| P1476 | title | BIOINFORMATIC ANALYSIS IDENTIFIES POTENTIALLY KEY DIFFERENTIALLY EXPRESSED GENES AND PATHWAYS IN ORBITAL ADIPOSE TISSUES OF PATIENTS WITH THYROID EYE DISEASE | |
| P478 | volume | -5 |
Search more.